Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Thoracic transplantation and stem cell therapy.

Walter Klepetko1, Günther Laufer, Alfred Kocher

  • 1Department of Cardio-Thoracic Surgery, Medical University Vienna, Waehringer Guertel 18-20, A- 1090 Vienna, Austria. walter.klepetko@meduniwien.ac.at

European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery
|March 22, 2005
PubMed
Summary

Lung and heart transplantation remain vital treatments for end-stage diseases. Future therapies may include cellular transplantation using stem cells for advanced disease management.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A.Kocher Technique: A Simplified Universally Applicable Approach for Aortic Root Enlargement.

Innovations (Philadelphia, Pa.)·2026
Same author

Organ transplantation in Fontan patients-beware of false promises.

JHLT open·2026
Same author

CT-Based Annular Dimensions in Transcatheter Mitral Valve Replacement: A Multicenter Registry Study.

The Annals of thoracic surgery·2026
Same author

The 10 Commandments for Oral Anticoagulation After Tissue Valve Replacement.

Innovations (Philadelphia, Pa.)·2026
Same author

Transcatheter Versus Minimally Invasive Surgical Aortic Valve Replacement With Rapid-Deployment Valves: A Propensity-Matched Analysis.

Interdisciplinary cardiovascular and thoracic surgery·2026
Same author

Simultaneous transcatheter edge-to-edge repair (TEER) for severe mitral and tricuspid regurgitation is feasible, safe, and associated with good clinical outcome.

PloS one·2026

Area of Science:

  • Regenerative Medicine
  • Transplantation Immunology
  • Cardiovascular and Pulmonary Medicine

Background:

  • Lung and heart transplantations are established treatments for end-stage organ failure.
  • These procedures are critical for improving patient survival and quality of life.
  • The demand for organ transplantation is projected to remain high.

Purpose of the Study:

  • To highlight the enduring importance of lung and heart transplantation.
  • To introduce the potential of cellular transplantation as a future therapeutic strategy.
  • To explore the role of stem cells in advanced organ disease treatment.

Main Methods:

  • Review of current transplantation literature.
  • Analysis of trends in end-stage organ disease management.

Related Experiment Videos

  • Exploration of emerging stem cell-based therapeutic approaches.

    • Main Results:

    • Lung and heart transplantation are indispensable in current medical practice.
    • Cellular transplantation, particularly using stem cells, shows promise as an innovative treatment.
    • Stem cell therapy offers a potential alternative or adjunct to traditional organ transplantation.

    Conclusions:

    • Lung and heart transplantation will continue to be crucial for end-stage diseases.
    • Cellular transplantation represents a significant advancement in therapeutic options.
    • Stem cell research is paving the way for novel regenerative approaches in transplantation.